Longjiang Di

Statistics

Publications

Citations

109

H-Index

Active since

2022

Affiliations

Shenzhen University(Current)

Shenzhen University Health Science Center

Harbin Medical University

Southern Medical University

Second Affiliated Hospital of Harbin Medical University

Longjiang Di is an author at Shenzhen University specializing in molecular biology, nlr family pyrin domain-containing 3 inflammasome, and cancer biomarkers.

ORCID

Publications per year

2022–2024

Publications

Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma

Jinbo Huang, Jiajie Su, Haiyu Wang et al. · Journal of Medicinal Chemistry · 2024 · 38 citations

Medicine, Medicinal Chemistry, Oncology +11

Platelet-derived microparticles stimulated by anti-β <sub>2</sub> GPI/β <sub>2</sub> GPI complexes induce pyroptosis of endothelial cells in antiphospholipid syndrome

Longjiang Di, Caijun Zha, Yanhong Liu · Platelets · 2022 · 24 citations · Full text

Life Sciences, Cell Biology, Immunology +17

SNAP25 is a potential prognostic biomarker for prostate cancer

Longjiang Di, Maoli Gu, Yan Wu et al. · Cancer Cell International · 2022 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +17

DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair

Huangqi Tang, Ya-Fei Lu, Rongsheng Zeng et al. · Proceedings of the National Academy of Sciences · 2024 · 17 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The role of H3K27me3 methylation in cancer development

Longjiang Di, Wei‐Guo Zhu · Genome Instability & Disease · 2024 · 11 citations

Life Sciences, Molecular Biology, Molecular Genetics +14

1–5 of 5